+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Doxorubicin"

Doxorubicin Global Market Report 2024 - Product Thumbnail Image

Doxorubicin Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Doxorubicin - Global Strategic Business Report - Product Thumbnail Image

Doxorubicin - Global Strategic Business Report

  • Report
  • May 2024
  • 288 Pages
  • Global
From
From
From
Ovarian Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Ovarian Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Gastric Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Gastric Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Anthracycline Global Market Report 2024 - Product Thumbnail Image

Anthracycline Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Sarcoma Drugs Global Market Report 2024 - Product Thumbnail Image

Sarcoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Thyroid Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Thyroid Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
From
Follicular Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Loading Indicator

Doxorubicin is an oncology drug used to treat a variety of cancers, including leukemia, lymphoma, and breast, ovarian, and bladder cancer. It is a type of anthracycline antibiotic, derived from Streptomyces peucetius, and works by interfering with the growth of cancer cells. It is administered intravenously, and is often used in combination with other drugs. Doxorubicin is one of the most widely used chemotherapy drugs, and is often used in combination with other drugs to treat a variety of cancers. It is also used to treat Kaposi's sarcoma, a type of skin cancer. Side effects of doxorubicin include nausea, vomiting, hair loss, and an increased risk of infection. The doxorubicin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more